Schedule 13G ownership disclosure

LIXTE BIOTECHNOLOGY HLDGS IN

Security class unavailable · CUSIP: 539319202

Event date: 2021-02-26

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
1,081,081
Percent of class
7.9900%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001535610-21-000083
Form type
SC 13G
Filer
LIXTE BIOTECHNOLOGY HOLDINGS, INC.
CIK
CIK 1335105
Filed
Mar 03, 2021
Reporting period
Feb 26, 2021
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub